Atopic hypersensitivity to L-asparaginase. Resistance to immunosuppression.
D000042:Absorption; D000818:Animals; D000906:Antibodies / Q000032:analysis; D000917:Antibody Formation / Q000187:drug effects; D001215:Asparaginase / Q000009:adverse effects* / Q000097:blood / Q000494:pharmacology; D001798:Blood Proteins / Q000032:analysis; D002648:Child; D002675:Child, Preschool; D004342:Drug Hypersensitivity; D005260:Female; D006168:Guinea Pigs; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000517:prevention & control; D007106:Immune Sera; D007116:Immunization, Passive; D005779:Immunodiffusion; D007073:Immunoglobulin E; D007074:Immunoglobulin G / Q000032:analysis; D007166:Immunosuppressive Agents; D007223:Infant; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008297:Male; D011233:Precipitin Tests; D012882:Skin Tests
D000906:Antibodies; D001798:Blood Proteins; D007106:Immune Sera; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D007073:Immunoglobulin E; D001215:Asparaginase